South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety...
-
Upload
antoine-sweeting -
Category
Documents
-
view
214 -
download
1
Transcript of South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety...
![Page 1: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/1.jpg)
South London and Maudsley (SLaM)IAPT-SMI Demonstration Site for Psychosis
Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group
Thursday 7 March 2013
![Page 2: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/2.jpg)
Research suggests that only 1 in 10 access CBT, despite NICE guidance (Schizophrenia Commission, 2012)
Service users want equal access to psychological therapies Rethink survey (2010)
![Page 3: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/3.jpg)
![Page 4: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/4.jpg)
The Abandoned IllnessThe Schizophrenia Commission
“Research has led to a range of evidence-based psychological treatments. We know much more about ‘what works’ than we used to. . . The committed individuals who went into the mental health profession to improve lives should be helped to do exactly that.”
Prof Sir Robin Murray
This is where IAPT-SMI comes in
![Page 5: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/5.jpg)
Obstacles to accessObstacles to access
![Page 6: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/6.jpg)
Dolly Sen, Service User Consultant
“I always asked for some kind of psychological therapy or talking therapy but was told, no, it was too dangerous. I had to wait 20 years for something that was the most beneficial thing. [Therapy] has changed my life basically.”
Talking to Norman Lamb on 19 December 2012
![Page 7: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/7.jpg)
94% have encountered obstacles in making psychological therapies available, including insufficient skilled staff
69% of Trusts have funding challenges for providing access to psychological therapies for people with a diagnosis of schizophrenia
![Page 8: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/8.jpg)
Delays in accessing CBTpPeters et al 2009
(N=74)
• Mean length of illness was 8 years (range 0-32)• Mean of 2.8 in-patient admissions (range 0-20)• 96% were on antipsychotic medication
![Page 9: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/9.jpg)
South London and Maudlsey NHS Foundation Trust: the context
• Core population - 4 South London Boroughs 1.3million; inner city, very high indices of social deprivation
• Substantially raised rates of psychosis
• Psychosis Care Pathways
![Page 10: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/10.jpg)
SLaM Psychosis Demonstration site: Increasing access in two care pathways
Promoting Recovery Pathway (Southwark, Croydon & Lewisham)
Promoting Recovery Pathway (Lambeth)
Early Intervention Pathway (Southwark, Lambeth, Croydon & Lewisham)
IAPT-EIIAPT-EI
IAPT-IAPT-SHARPSHARP
IAPT-IAPT-PICuPPICuP
![Page 11: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/11.jpg)
![Page 12: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/12.jpg)
![Page 13: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/13.jpg)
SHARPSHARP
![Page 14: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/14.jpg)
What IAPT-SMI offers for service users
CBT for psychosis:
• weekly or fortnightly individual 1 hour sessions• 6-9 months therapy• Therapists receive weekly-fortnightly group
supervision
FI for psychosis:
• Fortnightly 1 hour sessions with client and carer(s)• Up to ten sessions, over a period of 3-9 months• Therapy delivered by two trained therapists• Therapists receive weekly-fortnightly group
supervision
![Page 15: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/15.jpg)
Overcoming obstacles to accessOvercoming obstacles to access
![Page 16: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/16.jpg)
Work we have already done in SLaM• Ten point charter addressing
barriers and facilitators:– Service user involvement– Quality criteria and staff
training– Data gathering, data
systems and outcomes– Care pathways, ensuring
integrated effective care in Early Intervention & Recovery pathways
![Page 17: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/17.jpg)
Psychological treatments are Psychological treatments are not a quasi - medicationnot a quasi - medication
=
![Page 18: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/18.jpg)
Quality• One key challenge has been a lack of clarity about quality –
psychological therapy is different from a chemical compound• Lack of criteria have resulted in an ‘anything goes’ approach to
psychological therapy in MH services, and inflated estimates of provision
• We need nationally agreed criteria for training and competencies in CBTp and FI
• IAPT-SMI is doing this• Locally we have already developed criteria and standards and
established a portfolio of training opportunities
![Page 19: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/19.jpg)
Training and SupervisionTraining and Supervision
![Page 20: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/20.jpg)
Training and Supervision
• Portfolio of training opportunities in psychological therapies for psychosis, in partnership with KCL
• Span the workforce from non-clinical to managerial/supervisory
• Academically accredited training and in-service courses• Short courses and modules build to an award• Supervised practice strongly emphasised• Supervision and support for supervisors
![Page 21: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/21.jpg)
Training structure in the SLaM site
![Page 22: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/22.jpg)
Service user and caregiver involvement & co-production
• Involvement in development, design and evaluation of psychological therapy services
• Training design and delivery
• Co-produced workshops at SHARP and in the SLaM Recovery college
• Co-working in group interventions: Hearing Voices; Mindfulness; Acceptance & Commitment Therapy
• Training, supervision and support (practical, financial and emotional)
• Personal development – CPD, co-authorship, conference attendance
![Page 23: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/23.jpg)
SLaM demonstration site strategic approach to improving access to therapy
• A 50% increase in access with the funding provided • Reduced waiting times • Implementation of our 10 Point Charter, with highly
trained staff, and care pathways• Clear referral pathways, including self referral• Regular assessment of progress in therapy• Close and frequent supervision• Assessing improvement in a range of outcomes and
in health economics
![Page 24: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/24.jpg)
EffectivenessEffectiveness
![Page 25: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/25.jpg)
Clinical outcomes: Service-user reported symptoms
Clinical outcomes: Service-user reported symptoms
![Page 26: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/26.jpg)
15
20
25
30
Assessment (N=96,125)
Before therapy (N=70,80)
End of therapy (N=85,113)
Vo
ice
s
6
8
10
12
14
16
De
lus
ion
s
VoicesDelusions
This graph shows a reduction in psychotic symptoms [voices (effect size: .73) and delusions (effect size: .59)]
following therapy (PICuP)PICuP)
89% (voices) & 90% (delusions) have paired data at end of therapy
Evidence of clinical outcomes with Evidence of clinical outcomes with medium-large effect sizes medium-large effect sizes
– – voices and delusionsvoices and delusions
![Page 27: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/27.jpg)
14
16
18
20
22
24
26
Assessment (N=176) Before therapy (118) End of therapy (148,152)
De
pre
ss
ion
14
16
18
20
22
24
An
xie
ty
Depression
Anxiety
This graph shows a reduction in emotional problems [anxiety (effect size: .47) and depression (effect size: .55)]
following therapy PICuPPICuP
85% have paired data at end of therapy
Evidence of clinical outcomes with medium-Evidence of clinical outcomes with medium-large effect sizes – anxiety and depressionlarge effect sizes – anxiety and depression
![Page 28: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/28.jpg)
44
46
48
50
52
54
Before therapy (174; 113) End of therapy (131, 76)
MA
NS
A
80
90
100
110
120
130
140
CH
OIC
E
QoL
Recovery
85% (QoL) & 67% (CHOICE) have paired data at end of therapy
Evidence of clinical outcomes with medium-Evidence of clinical outcomes with medium-large effect sizes – quality of life (QoL) and large effect sizes – quality of life (QoL) and
recoveryrecovery
This graph shows an increase in people’s quality of life (measured on the Manchester Short Assessment of Quality of Life; effect size: .51) and recovery ratings (measured on the
CHOICE; effect size .79) following therapy
![Page 29: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/29.jpg)
Cost-effectivenessCost-effectiveness
![Page 30: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/30.jpg)
£7236£6602
£9018
£12,558
0
2000
4000
6000
8000
10000
12000
14000
Therapy(baseline)
Control(baseline)
Therapy(follow-up)
Control(follow-up)
Mea
n 9-
mon
th c
ost
(200
5/6
£s)
TherapyInpatient careNon-inpatient care
Randomised Controlled Trial (Peters et al, 2010) – therapy costs are off-set by fewer inpatient costs at 3 months follow-up
(N = 74)
![Page 31: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/31.jpg)
0
100
200
300
400
500
1 year prior to therapy 1 year following therapy
451.46
172.24
Cost
s per
mon
th (£
)Reduction in service-use costs (admissions & home treatment team days) in the year following therapy, compared to the year
prior to therapy (Wilcoxon test: p <.05*)
N = 70
Data obtained from ePJS, Jan 2012
![Page 32: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/32.jpg)
Progress and preliminary outcomesProgress and preliminary outcomes
![Page 33: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/33.jpg)
![Page 34: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/34.jpg)
Variable New clients in the service
Age distribution Mean 38 years (18-70)
Gender 43% male, 57% female
Ethnicity 36% white, 64% BME
New clients - demographics
![Page 35: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/35.jpg)
Demonstration site CBTp & FIp Demonstration site CBTp & FIp referral targets are being achievedreferral targets are being achieved
Existing Projection Monthly Referral Target
(over 12m)
Progress at 4 months
CBT FI CBT FI CBT FI CBT FI
106 15 50 10 14 2-3 95 11
![Page 36: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/36.jpg)
Waiting times are reduced (in days)Waiting times are reduced (in days)
Referral received to
opted-in
Opted-in to
assessed
Assessed to
receiving therapy
Total%
reduction in waiting
times
35 7 23 57 60%
![Page 37: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/37.jpg)
Health Utilisation data Health Utilisation data
Service Mean number of days in 12m before therapy
Mental health admission 10.5 (0-126)
Crisis team / home treatment 0.7 (0-23)
Psychiatric liaison (A&E) 0.1 (0-2)
![Page 38: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/38.jpg)
IAPT-SMI: CBT assessments
Short CHOICE weekly
![Page 39: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/39.jpg)
IAPT-SMI: Carer assessments
![Page 40: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/40.jpg)
Patient Reported Outcome MeasuresPatient Reported Outcome Measures
Measure Completion rate
Session by session short CHOICE
81% of attended sessions
Pre-therapy:PSYRATSQuestionnaires
98%100%
![Page 41: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/41.jpg)
London Tonight report from 19 December 2012 – visit to SLaM by Norman Lamb, Care and Support Minister and the official launch of the IAPT-SMI demonstration sites:
http://www.itv.com/news/london/update/2012-12-20/maudsley-hospital-pioneers-mental-health-therapy-scheme/
![Page 42: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/42.jpg)
Operational Group
Dr Louise Johns,Project Lead
Dr Miriam Fornells-Ambrojo,IAPT-EI Lead
Rosanna Michalczuk Bina Sharma Psychology Assistants
Dr Suzanne Jolley,Lambeth RecoveryPsychology Lead
Dr Juliana Onwumere, FI Lead
Dr Craig Milosh, Clinical Psychologist, SHARP
Devon Elliott, Business Intelligence Analyst
![Page 43: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/43.jpg)
Steering Group• Lucy Canning, Psychosis CAG Service Director• Prof Philippa Garety, Psychosis CAG Clinical Director• Jonathan Beder, Psychosis CAG Deputy Director, Business and Performance• Dolly Sen and Garry Ellison, Service User consultants • Roger Oliver and Lorna Wilkinson, Carer consultants• Prof Tom Craig, Consultant Psychiatrist, SHARP• Marieke Wrigley, Team Leader, SHARP• Prof Elizabeth Kuipers, NICE Schizophrenia guideline lead• Dr Emmanuelle Peters, PICuP Director• Adrian Webster, CAG Psychological Therapies Lead• Jo Lawrence, Clinical Service Lead, EI• Dr Sarah Dilks, Lead Psychologist, Promoting Recovery pathway• Dr Eric Morris, Lead Psychologist, Early Intervention pathway• Penelope Fell, Head of Business Development• Dorothy Abrahams, Administrator
![Page 44: South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Professor Philippa Garety Clinical Director, Psychosis Clinical Academic Group.](https://reader036.fdocuments.in/reader036/viewer/2022070307/551b323d550346d41a8b4f0f/html5/thumbnails/44.jpg)
Thank you for listening!You are welcome to our SLaM
Demonstration Site Visit
Thank you for listening!You are welcome to our SLaM
Demonstration Site Visit
Monday 1 July 2013 Monday 1 July 2013 1.00-5.00 pm1.00-5.00 pm
[email protected]@slam.nhs.uk